JJR Capital Corp. is a Toronto based merchant bank that specializes in reverse merger transactions with an international investment focus. Our team of highly skilled and experienced finance, legal and consulting professionals brings a unique solution and approach to financing companies with enterprise values ranging from $50m to $300m.
A New Chapter for Hudson - JJR Capital Corp. is playing a key role in the reverse transaction
Barry Critchley, Financial Post • Oct. 06, 2011
The stage has been set for the return of Steve Hudson, one of the founders of Newcourt Credit Group, to the public capital markets.
Mr. Hudson, who organized the sale of Newcourt to CIT a decade ago, will be in the public markets again, thanks to Mira 11 Acquisition Corp., a capital pool company listed on the TSX Venture Exchange, entering a letter of intent to acquire Element Financial Corp., an equipment leasing company that Mr. Hudson set up two years ago. The deal will be done by way of a reverse takeover with the now private Element ending up as the resulting public company. (read)
OCTOBER 5, 2011. JJR CAPITAL ANNOUNCED PROPOSED QUALIFYING TRANSACTION OF MIRA II ACQUISITION CORP. WITH ELEMENT FINANCIAL CORPORATION
Mira II Acquisition Corp. has entered into a letter of intent dated Oct. 4, 2011, with Element Financial Corp. to complete a going public transaction for Element by way of a reverse takeover of Mira II, a capital pool company listed on the TSX Venture Exchange. The proposed transaction will be conducted by way of an amalgamation under the Business Corporations Act (Ontario) pursuant to which Element will combine its corporate existence with Mira II, with the amalgamated entity being named Element Financial Corp. (read)
Melnyk's next big move – Merger of JJR and Trimel BioPharma
Barry Critchley, Financial Post • Feb. 25, 2011
He did it once and turned Biovail Corp. into one of the country's largest specialty pharmaceutical companies and along the way attracted attention from investors, customers - and the regulators.
Now Eugene Melnyk is back, hoping to create the next Biovail. J5 Acquisition Corp., a capital pool company, announced a letter of intent with Trimel BioPharama Holdings Inc., the private company Melnyk set up in 2008. If things work out as planned, J5 will merge with Trimel, Trimel will also do a private round of equity financing and Trimel will be the resulting public company. (read)
JJR AND TRIMEL BIOPHARMA HOLDINGS INC. ANNOUNCE A PROPOSED QUALIFYING TRANSACTION
JJR Capital Corp is pleased to announce that J5 Acquisition Corp., together with its wholly owned subsidiary incorporated under the laws of Barbados, J5 (Barbados) Inc., entered into a definitive agreement to amalgamate with Trimel BioPharma Holdings Inc. dated March 2, 2011, to complete an arm's-length qualifying transaction with Trimel. Under the proposed transaction, J5 will acquire all of the issued and outstanding common shares of Trimel, such that Trimel will become a wholly owned subsidiary of J5. The amalgamation agreement will be made available on SEDAR. The resulting issuer will apply to the Toronto Stock Exchange to have its common shares listed for trading immediately following the proposed transaction. (read)
Read more news and announcements
Barry Critchley, Financial Post • Oct. 06, 2011
The stage has been set for the return of Steve Hudson, one of the founders of Newcourt Credit Group, to the public capital markets.
Mr. Hudson, who organized the sale of Newcourt to CIT a decade ago, will be in the public markets again, thanks to Mira 11 Acquisition Corp., a capital pool company listed on the TSX Venture Exchange, entering a letter of intent to acquire Element Financial Corp., an equipment leasing company that Mr. Hudson set up two years ago. The deal will be done by way of a reverse takeover with the now private Element ending up as the resulting public company. (read)
OCTOBER 5, 2011. JJR CAPITAL ANNOUNCED PROPOSED QUALIFYING TRANSACTION OF MIRA II ACQUISITION CORP. WITH ELEMENT FINANCIAL CORPORATION
Mira II Acquisition Corp. has entered into a letter of intent dated Oct. 4, 2011, with Element Financial Corp. to complete a going public transaction for Element by way of a reverse takeover of Mira II, a capital pool company listed on the TSX Venture Exchange. The proposed transaction will be conducted by way of an amalgamation under the Business Corporations Act (Ontario) pursuant to which Element will combine its corporate existence with Mira II, with the amalgamated entity being named Element Financial Corp. (read)
Melnyk's next big move – Merger of JJR and Trimel BioPharma
Barry Critchley, Financial Post • Feb. 25, 2011
He did it once and turned Biovail Corp. into one of the country's largest specialty pharmaceutical companies and along the way attracted attention from investors, customers - and the regulators.
Now Eugene Melnyk is back, hoping to create the next Biovail. J5 Acquisition Corp., a capital pool company, announced a letter of intent with Trimel BioPharama Holdings Inc., the private company Melnyk set up in 2008. If things work out as planned, J5 will merge with Trimel, Trimel will also do a private round of equity financing and Trimel will be the resulting public company. (read)
JJR AND TRIMEL BIOPHARMA HOLDINGS INC. ANNOUNCE A PROPOSED QUALIFYING TRANSACTION
JJR Capital Corp is pleased to announce that J5 Acquisition Corp., together with its wholly owned subsidiary incorporated under the laws of Barbados, J5 (Barbados) Inc., entered into a definitive agreement to amalgamate with Trimel BioPharma Holdings Inc. dated March 2, 2011, to complete an arm's-length qualifying transaction with Trimel. Under the proposed transaction, J5 will acquire all of the issued and outstanding common shares of Trimel, such that Trimel will become a wholly owned subsidiary of J5. The amalgamation agreement will be made available on SEDAR. The resulting issuer will apply to the Toronto Stock Exchange to have its common shares listed for trading immediately following the proposed transaction. (read)
Read more news and announcements
